Literature DB >> 9740069

Nasopharyngeal carcinoma in situ: two cases of an emerging diagnostic entity.

F Cheung1, S W Pang, F Hioe, K N Cheung, A Lee, T K Yau.   

Abstract

BACKGROUND: The association of Epstein-Barr virus (EBV) with the oncogenesis of nasopharyngeal carcinoma (NPC) is well established. Latent infection by EBV with clonal proliferation has also been demonstrated in preinvasive lesions of NPC. In situ hybridization for EBV-encoded RNA (ISH EBER) now serves as an ancillary test in the definitive diagnosis of these lesions.
METHODS: Two cases of nasopharyngeal carcinoma in situ (NPCIS) are presented in this study. Their biopsies were studied by ordinary light microscopy, the ISH EBER technique, and immunostaining for bcl-2. Tissue samples from 100 high risk subjects negative for NPC and NPCIS, who served as controls, were also studied using the ISH EBER technique.
RESULTS: NPCIS was characterized by abnormal light microscopic appearance as well as positive staining by the ISH EBER technique; these features were not observed in samples from the 100 high risk subjects. Immunostaining for bcl-2 protein was positive but less specific. Postradiotherapy biopsies of the two patients were negative for NPCIS.
CONCLUSIONS: With the help of the ISH EBER technique, the diagnosis of NPCIS is now possible in routine surgical pathology. As this entity is rare, it is necessary to have a high degree of suspicion when evaluating biopsies from high risk individuals. Radiotherapy for patients with NPCIS is justified in view of the risk of cancer progression and the possibility of a coexisting invasive carcinoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740069

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  An update on Epstein-Barr virus and nasopharyngeal carcinogenesis.

Authors:  Bayardo Perez-Ordoñez
Journal:  Head Neck Pathol       Date:  2007-12-01

2.  Epstein-Barr virus nuclear antigen-1 is useful as therapeutic efficacy marker in serum but not in saliva of nasopharyngeal cancer patients who underwent radiotherapy.

Authors:  Yurnadi H Midoen; Dwi A Suryandari; Luluk Yunaini; Raden Susworo; Elza I Auerkari; Hans-Joachim Freisleben
Journal:  Ecancermedicalscience       Date:  2021-06-21

3.  Genetic polymorphisms of TLR3 are associated with Nasopharyngeal carcinoma risk in Cantonese population.

Authors:  Jun-Fang He; Wei-Hua Jia; Qin Fan; Xin-Xi Zhou; Hai-De Qin; Yin Yao Shugart; Yi-Xin Zeng
Journal:  BMC Cancer       Date:  2007-10-17       Impact factor: 4.430

4.  Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer.

Authors:  Rungnapa Hirunsatit; Narisorn Kongruttanachok; Kanjana Shotelersuk; Pakpoom Supiyaphun; Narin Voravud; Anavaj Sakuntabhai; Apiwat Mutirangura
Journal:  BMC Genet       Date:  2003-01-21       Impact factor: 2.797

5.  Functional polymorphism in the 5'-UTR of CR2 is associated with susceptibility to nasopharyngeal carcinoma.

Authors:  Qin Fan; Jun-Fang He; Qi-Rui Wang; Hong-Bing Cai; Xue-Gang Sun; Xin-Xi Zhou; Hai-De Qin; Yin Yao Shugart; Wei-Hua Jia
Journal:  Oncol Rep       Date:  2013-04-23       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.